In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Recent advances in the genomics of childhood cancer may help inform potential causes and better treatment strategies.
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
Former Philadelphia Mayor Michael Nutter received a humanitarian award for his work as a prostate cancer advocate and dedication...
Researchers examined how the molecular features of Hodgkin lymphomas differ between young and older patients.
Bianca Islam, MD, PhD, examines how social determinants of health impact cancer patients and what is being done to...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
The Global Scholar Alumni Committee reflects on their progress after the first year in helping the careers of young...
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...